Non-Interventional Study on the Tolerability and Efficacy of Octagam 10% - GAM10-06 "GammaTrack"

Trial Profile

Non-Interventional Study on the Tolerability and Efficacy of Octagam 10% - GAM10-06 "GammaTrack"

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 14 Oct 2016

At a glance

  • Drugs Immune globulin (Primary)
  • Indications Graft-versus-host disease; Immunodeficiency disorders
  • Focus Adverse reactions
  • Acronyms GammaTrack
  • Sponsors Octapharma
  • Most Recent Events

    • 07 Oct 2016 Planned End Date changed from 1 Mar 2017 to 1 Dec 2017.
    • 07 Oct 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
    • 07 Oct 2016 Planned initiation date changed from 1 Sep 2015 to 1 Mar 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top